Your browser doesn't support javascript.
loading
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
Ademuyiwa, Foluso O; Gao, Feng; Street, Cherease R; Chen, Ina; Northfelt, Donald W; Wesolowski, Robert; Arora, Mili; Brufsky, Adam; Dees, E Claire; Santa-Maria, Cesar A; Connolly, Roisin M; Force, Jeremy; Moreno-Aspitia, Alvaro; Herndon, John M; Carmody, Madelyn; Davies, Sherri R; Larson, Sarah; Pfaff, Kathleen L; Jones, Stephanie M; Weirather, Jason L; Giobbie-Hurder, Anita; Rodig, Scott J; Liu, Zheng; Hagemann, Ian S; Sharon, Elad; Gillanders, William E.
Afiliación
  • Ademuyiwa FO; Washington University School of Medicine, St Louis, MO, 63110, USA. bisiademuyiwa@wustl.edu.
  • Gao F; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Street CR; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Chen I; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Northfelt DW; Mayo Clinic, Phoenix, AZ, 85054, USA.
  • Wesolowski R; Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.
  • Arora M; UC Davis Comprehensive Cancer Center, Sacramento, CA, 95817, USA.
  • Brufsky A; University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
  • Dees EC; University of North Carolina School of Medicine, Chapel Hill, NC, 27514, USA.
  • Santa-Maria CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA.
  • Connolly RM; University College Cork, Cork, Ireland.
  • Force J; Duke University School of Medicine, Durham, NC, 27710, USA.
  • Moreno-Aspitia A; Mayo Clinic, Jacksonville, FL, 32224, USA.
  • Herndon JM; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Carmody M; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Davies SR; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Larson S; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Pfaff KL; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Jones SM; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Weirather JL; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Giobbie-Hurder A; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Rodig SJ; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Liu Z; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Hagemann IS; Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Sharon E; National Cancer Institute, Bethesda, MD, 20892, USA.
  • Gillanders WE; Washington University School of Medicine, St Louis, MO, 63110, USA. gillandersw@wustl.edu.
NPJ Breast Cancer ; 8(1): 134, 2022 Dec 30.
Article en En | MEDLINE | ID: mdl-36585404
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: NPJ Breast Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: NPJ Breast Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos